National Forensic Laboratory Information System (NFLIS)

Overview

The DEA National Forensic Laboratory Information System (NFLIS) systematically collects results from drug chemistry analyses conducted by state and local forensic laboratories across the country. As a national drug forensic laboratory reporting system, NFLIS provides timely and detailed analytical results of drugs seized by law enforcement. It is a unique source of information for monitoring and understanding drug abuse and trafficking in the United States, including the diversion of legally manufactured drugs into illegal markets. Findings from NFLIS can also supplement existing drug data sources, including information from drug demand surveys and drug testing programs.

Over 300 state and local forensic laboratories in the United States perform nearly two million drug analyses each year. As of March 2012, 48 state laboratory systems and 91 local laboratory systems, representing 288 individual laboratories, are participating in NFLIS. In 2011, approximately 1.7 million drug analysis records were reported to NFLIS. This information is made available through semiannual, annual, and special reports. These reports include findings on major drug categories such as narcotic analgesics, depressants and tranquilizers, hallucinogens, anabolic steroids, and stimulants. They provide statistically representative national and regional drug item estimates for the most frequently identified drugs. National case estimates for the most frequently identified drugs are also presented.

NFLIS is one resource of information utilized by DEA to carry out its core mission. The NFLIS information system supports DEA's ability to track national, regional, and local drug patterns, including providing timely and geographically specific information on emerging drug problems. Over the next several years, DEA will seek to expand the NFLIS program to include all federal, state, and local laboratories that perform drug chemical analyses.

Contact Us

Publications

The following are publications produced by the NFLIS project. These include annual, midyear, and special reports. All PDF reports require Adobe Acrobat Reader for viewing.

2016

Special Report: Synthetic Cannabinoids and Synthetic Cathinones Reported in NFLIS, 2013–2015 (File size 1,525 KB)

2015 Annual Report (File size 7MB)

2015 Midyear Report (File size 1MB)

2015

2014 Annual Report (File size 8.52MB)

2014 Midyear Report (Revised March 2016) (File size 1.86MB)

Statistical Methodology, 2014 (File size 400KB)

Special Report: Opiates and Related Drugs Reported in NFLIS, 2009-2014 (Revised February 2016) (File size 2.5MB)

Special Report: Benzodiazepines Reported in NFLIS, 2009–2014 (File size 2MB)

2014

2013 Annual Report (File size 8.36MB)

2013 Midyear Report (File size 2.4MB)

2013 Survey of Crime Laboratory Drug Chemistry Sections (File size 1.36MB)

Special Report: Synthetic Cannabinoids and Synthetic Cathinones Reported in NFLIS, 2010–2013 (File size 3.87MB)

2013

2012 Annual Report (File size 6.44MB)

2012 Midyear Report (File size 1.12MB)

2012

2011 Annual Report (File size 5.24MB)

2011 Midyear Report (File size 1.79MB)

Special Report: ADD/ADHD Stimulants in NFLIS, 2007-2011 (File size 1.07MB)

Special Report: Emerging 2C-Phenethylamines, Piperazines, and Tryptamines in NFLIS, 2006-2011 (File size 7.55MB)

2011

NFLIS Estimates Methodology (File size 265KB)

2010 Annual Report (File size 14.49MB)

2010 Midyear Report (File size 6.26MB)

Special Report: Synthetic Cannabinoids and Synthetic Cathinones Reported in NFLIS, 2009-2010 (File size 1.72MB)

2010

2009 Annual Report (File size 18.34MB)

2009

2009 Midyear Report (File size 5.38MB)

2008 Annual Report (File size 8.35MB)

Special Report: Methadone and Buprenorphine, 2003-2008 (File size 1.86MB)

2008

2008 Midyear Report (File size 5.2MB)

2007 Annual Report (File size 5.5MB)

2007

2007 Midyear Report (File size 5.51MB)

2006 Annual Report (File size 10.72MB)

Special Report: Fentanyl 2003-2006 (File size 2.32MB)

2006

2006 Midyear Report (File size 3MB)

2005 Annual Report (File size 7.06MB)

Special Report: Controlled Substance Prescription Drugs, 2001-2005 (File size 1.48MB)

2005

2005 Midyear Report (File size 3.09MB)

2004 Annual Report (File size 6.44MB)

Special Report: Synthetic Drugs, 2001-2004 (File size 3.23MB)

2004

2004 Midyear Report (File size 1.92MB)

2003 Annual Report (File size 17.27MB)

2003

2003 Midyear Report (File size 4.48MB)

2002 Annual Report (File size 6.51MB)

Special Report: Narcotic Analgesics 2001-2003 (File size 3MB)

2002

2002 4th Quarterly Report (File size 329KB)

2002 3rd Quarterly Report (File size 322KB)

2002 2nd Quarterly Report (File size 319KB)

2002 1st Quarterly Report (File size 776KB)

2001 Annual Report (File size 6.66MB)

2001

2001 4th Quarterly Report (File size 698KB)

2001 3rd Quarterly Report (File size 707KB)

2001 2nd Quarterly Report (File size 187KB)

2001 1st Quarterly Report (File size 1.02MB)

2000 Annual Report (File size 2.37MB)